144 related articles for article (PubMed ID: 12660041)
1. Trisomy X in Philadelphia chromosome-negative cells during the course of Philadelphia chromosome-positive chronic myelocytic leukemia.
Hishida A; Yamamoto K; Matsushita T; Tanimoto M; Saito H; Emi N
Cancer Genet Cytogenet; 2003 Apr; 142(1):83-5. PubMed ID: 12660041
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosome.
Ohtsuka E; Kikuchi H; Abe Y; Moriyama K; Ohno E; Hirota K; Tezono K; Nasu M
Br J Haematol; 1995 Aug; 90(4):951-3. PubMed ID: 7669678
[TBL] [Abstract][Full Text] [Related]
3. Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia.
Ariyama T; Inazawa J; Uemura Y; Kakazu N; Maekawa T; Urase F; Irimajiri K; Horiuchi A; Nakamura Y; Abe T
Cancer Genet Cytogenet; 1995 May; 81(1):20-3. PubMed ID: 7773954
[TBL] [Abstract][Full Text] [Related]
4. A second case of trisomy 8 in Philadelphia chromosome (Ph)-negative cells during the course of Ph-positive chronic myelocytic leukemia.
Bilhou-Nabera C; Marit G; Devianne I; Viard F; Salzes S; Montastruc M; Renoux M; Broustet A; Reiffers J; Bernard P
Genes Chromosomes Cancer; 1993 Apr; 6(4):255-6. PubMed ID: 7685633
[TBL] [Abstract][Full Text] [Related]
5. Trisomy 8 in Philadelphia chromosome (Ph1)-negative cells in the course of Ph1-positive chronic myelocytic leukemia.
Casali M; Truglio F; Milone G; Di Raimondo F; Parrinello G; Maserati E; Pasquali F
Genes Chromosomes Cancer; 1992 Apr; 4(3):269-70. PubMed ID: 1382571
[TBL] [Abstract][Full Text] [Related]
6. Extensive cytogenetic studies of clonality following interferon-alpha therapy in chronic myeloid leukemia occurring in monosomic cells in a patient with Turner syndrome mosaic.
Takeshita A; Shinjo K; Yamashita M; Fujisawa S; Naito K; Ohnishi K; Takahashi K; Matsui H; Ohno R
Leukemia; 1999 Nov; 13(11):1749-53. PubMed ID: 10557048
[TBL] [Abstract][Full Text] [Related]
7. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea.
Flamm MJ; Murty VV; Rao PH; Nichols GL
Leuk Res; 2002 Apr; 26(4):417-20. PubMed ID: 11839390
[TBL] [Abstract][Full Text] [Related]
9. CML clonal evolution with resistance to single agent imatinib therapy.
Swords R; Quinn J; Fay M; O'Donnell R; Goldman J; Murphy PT
Clin Lab Haematol; 2005 Oct; 27(5):347-9. PubMed ID: 16178920
[TBL] [Abstract][Full Text] [Related]
10. Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.
Kim M; Lee S; Jung CK; Lim J; Cho SG; Kim DW; Kim Y; Han K; Min WS; Kim CC
Int J Lab Hematol; 2008 Dec; 30(6):508-12. PubMed ID: 18983302
[TBL] [Abstract][Full Text] [Related]
11. Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia.
Wahlin A; Golovleva I
Eur J Haematol; 2003 Apr; 70(4):240-1. PubMed ID: 12656748
[TBL] [Abstract][Full Text] [Related]
12. Remission of Philadelphia positive chronic myelogenous leukemia associated with t(3;21) after bone marrow transplantation.
Uriarte MR; Mori MA; de Bellis R; Cardoso H
Cancer Genet Cytogenet; 1993 Jul; 68(2):122-5. PubMed ID: 8353803
[TBL] [Abstract][Full Text] [Related]
13. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
14. Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph1-positive chronic myelogenous leukemia.
Izumi T; Imagawa S; Hatake K; Miura Y; Ariyama T; Inazawa J; Abe T
Int J Hematol; 1996 Jul; 64(1):73-7. PubMed ID: 8757971
[TBL] [Abstract][Full Text] [Related]
15. Development and progression of a Philadelphia-chromosome-negative acute myelocytic leukemia clone in a patient with Philadelphia-chromosome-positive chronic myelocytic leukemia.
Cullen MJ; Richards SJ; Dickinson H; Carter C; Swirsky DM; Owen RG
Cancer Genet Cytogenet; 2004 Jan; 148(2):170-3. PubMed ID: 14734234
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia-positive chronic myelogenous leukemia with a 5q-- abnormality in a patient following interferon-alpha therapy.
Zámecníkova A; Krizana P; Gyarfás J; Vahancík A
Cancer Genet Cytogenet; 2001 Jun; 127(2):134-9. PubMed ID: 11425452
[TBL] [Abstract][Full Text] [Related]
17. A fertile XY/XX chimeric male with chronic myeloid leukemia in a minor 46,XX cell line and a history of polycythemia vera and trisomy 9 in the major 46,XY cell line.
Reddy KS; Schwartz GE; Jamedhor M
Leuk Lymphoma; 2009 Aug; 50(8):1375-80. PubMed ID: 19562617
[No Abstract] [Full Text] [Related]
18. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
Anger B; Porzsolt F; Leichtle R; Heinze B; Bartram C; Heimpel H
Blut; 1989 Jun; 58(6):275-8. PubMed ID: 2736308
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal relationship between a Ph-negative clone with trisomy 8 associated with severe myelodysplasia and a Ph-positive clone following imatinib treatment in a patient with accelerated-phase chronic myelogenous leukemia (CML).
Patchenko P; Klepfish A; Trakhtenbrot L; Rothman R; Rachmilewitz EA
Am J Hematol; 2004 Dec; 77(4):420. PubMed ID: 15558793
[No Abstract] [Full Text] [Related]
20. Ph-negative acute lymphocytic leukemia occurring after interferon therapy for Ph-positive chronic myelocytic leukemia.
Zhang X; Ji L; Liu S; Wang J
Leuk Res; 2003 Apr; 27(4):367-9. PubMed ID: 12531230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
